Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops

Title
Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops
Authors
Keywords
Nanomedicine, Glaucoma, Sustained release, Human subjects, Patient compliance, Liposomal latanoprost
Journal
Drug Delivery and Translational Research
Volume 4, Issue 4, Pages 303-309
Publisher
Springer Nature
Online
2014-03-31
DOI
10.1007/s13346-014-0196-9

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started